MedPath

Shanghai Fudan University Huashan Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer

Not Applicable
Recruiting
Conditions
Colorectal Neoplasms
Positron-Emission Tomography
Interventions
Radiation: [68Ga]Ga-NOTA-WWH347 or [18F]F-H3RESCA-WWH347
First Posted Date
2024-01-12
Last Posted Date
2024-02-20
Lead Sponsor
Huashan Hospital
Target Recruit Count
40
Registration Number
NCT06203587
Locations
🇨🇳

Huashan Hospital, Shanghai, China

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Not Applicable
Recruiting
Conditions
Neoplasms
Positron-Emission Tomography
Interventions
Radiation: [68Ga]Ga-NOTA-T4 or [18F]AlF-RESCA-T4
First Posted Date
2024-01-12
Last Posted Date
2024-06-18
Lead Sponsor
Huashan Hospital
Target Recruit Count
60
Registration Number
NCT06203574
Locations
🇨🇳

Huashan Hospital, Shanghai, China

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Not Applicable
Recruiting
Conditions
Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer
Interventions
Radiation: [131I]/[18F]/[68Ga]ZT-111
First Posted Date
2024-01-11
Last Posted Date
2024-01-25
Lead Sponsor
Huashan Hospital
Target Recruit Count
10
Registration Number
NCT06201741
Locations
🇨🇳

Huashan Hospital, Shanghai, China

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Early Phase 1
Not yet recruiting
Conditions
Pompe Disease (Late-onset)
Interventions
Genetic: CRG003 injection
First Posted Date
2023-12-21
Last Posted Date
2023-12-21
Lead Sponsor
Huashan Hospital
Target Recruit Count
6
Registration Number
NCT06178432
Locations
🇨🇳

Huashan Hospital of Fudan University, Shanghai, China

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients

Phase 4
Conditions
Cryptococcal Meningitis
Antifungal Agents
Interventions
Drug: Amphotericin B 0.7 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.
Drug: Amphotericin B 0.5 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.
First Posted Date
2023-12-21
Last Posted Date
2023-12-21
Lead Sponsor
Huashan Hospital
Target Recruit Count
250
Registration Number
NCT06178627
Locations
🇨🇳

Huashan Hospital, Shanghai, Shanghai, China

🇨🇳

The Fourth People's Hospital of Nanning, Nanning, China

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Not Applicable
Recruiting
Conditions
Non-small Cell Lung Cancer
Interventions
Radiation: [68Ga]Ga-NOTA-RW102 PET Imaging
First Posted Date
2023-12-12
Last Posted Date
2023-12-12
Lead Sponsor
Huashan Hospital
Target Recruit Count
20
Registration Number
NCT06165874
Locations
🇨🇳

Huashan Hospital, Shanghai, China

The Role of B7-H4 in Tumor Vaccine

Recruiting
Conditions
Glioma
Interventions
Biological: tumor vaccine
First Posted Date
2023-12-05
Last Posted Date
2023-12-05
Lead Sponsor
Huashan Hospital
Target Recruit Count
160
Registration Number
NCT06156150
Locations
🇨🇳

Di Chen, Shanghai, Shanghai, China

Subclinical TB With Innovative Modified Short-course Regimens

Phase 4
Active, not recruiting
Conditions
Tuberculosis
Interventions
Drug: Standard regimen
Drug: Short-course regimen
First Posted Date
2023-12-01
Last Posted Date
2023-12-14
Lead Sponsor
Huashan Hospital
Target Recruit Count
556
Registration Number
NCT06153069
Locations
🇨🇳

Huashan Hospital of Fudan University, Shanghai, Shanghai, China

🇨🇳

Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Not Applicable
Recruiting
Conditions
Kidney Cancer
Lymphomas
Positron Emission Tomography
Interventions
Radiation: [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT imaging
First Posted Date
2023-11-28
Last Posted Date
2024-02-16
Lead Sponsor
Huashan Hospital
Target Recruit Count
20
Registration Number
NCT06148220
Locations
🇨🇳

Huashan Hospital, Shanghai, China

[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the Brain

Not Applicable
Recruiting
Conditions
Positron Emission Tomography
Cerebral Gliosis
Interventions
Radiation: [18F]BF3-BPA Injection for PET Imaging
First Posted Date
2023-11-28
Last Posted Date
2023-11-28
Lead Sponsor
Huashan Hospital
Target Recruit Count
80
Registration Number
NCT06148207
Locations
🇨🇳

Huashan Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath